{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T22:51:18Z","timestamp":1777589478240,"version":"3.51.4"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T00:00:00Z","timestamp":1389139200000},"content-version":"vor","delay-in-days":99,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["ijidonline.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Infectious Diseases"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.ijid.2013.03.017","type":"journal-article","created":{"date-parts":[[2013,5,11]],"date-time":"2013-05-11T01:15:11Z","timestamp":1368234911000},"page":"e892-e896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Incidence and clinical and immunological characteristics of primary Toxoplasma gondii infection in HIV-infected patients"],"prefix":"10.1016","volume":"17","author":[{"given":"Ladislav","family":"Machala","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marek","family":"Mal\u00fd","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ond\u0159ej","family":"Beran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Jilich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Petr","family":"Kodym","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijid.2013.03.017_bib0005","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0891-5520(20)30196-3","article-title":"Toxoplasmic encephalitis in patients with AIDS","volume":"2","author":"Israelski","year":"1988","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.ijid.2013.03.017_bib0010","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/BF02768747","article-title":"The probability of acquiring primary Toxoplasma infection in HIV-infected patients: results of an 8-year retrospective study","volume":"26","author":"Reiter-Owona","year":"1998","journal-title":"Infection"},{"key":"10.1016\/j.ijid.2013.03.017_bib0015","first-page":"324","article-title":"[The prevalence and spread of HIV\/AIDS in the Czech Republic]","volume":"20","author":"Mal\u00fd","year":"2011","journal-title":"Zpr\u00e1vy CEM"},{"issue":"Suppl 3","key":"10.1016\/j.ijid.2013.03.017_bib0020","first-page":"3","article-title":"Amendment to standard laboratory methods for diagnosing toxoplasmosis","author":"Z\u00e1st\u011bra","year":"1987","journal-title":"Acta Hyg Epidemiol Microbiol"},{"key":"10.1016\/j.ijid.2013.03.017_bib0025","first-page":"355","article-title":"[Assessment of anti-toxoplasmic IgG by the ELISA method]","volume":"39","author":"Pokorn\u00fd","year":"1989","journal-title":"\u010cesk Epidemiol Mikrobiol Imunol"},{"key":"10.1016\/j.ijid.2013.03.017_bib0030","first-page":"57","article-title":"[Assessment of anti-toxoplasmic IgM by the ELISA method]","volume":"39","author":"Pokorn\u00fd","year":"1990","journal-title":"\u010cesk Epidemiol Mikrobiol Imunol"},{"key":"10.1016\/j.ijid.2013.03.017_bib0035","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1469-0691.2006.01564.x","article-title":"Evaluation of a commercial IgE ELISA in comparison with IgA and IgM ELISAs, IgG avidity assay and complement fixation for the diagnosis of acute toxoplasmosis","volume":"13","author":"Kodym","year":"2007","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2013.03.017_bib0040","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1086\/515147","article-title":"Incidence and risk factors of toxoplasmosis in a cohort of human immunodeficiency virus-infected patients: 1988-1995. HEMOCO and SEROCO Study Groups","volume":"28","author":"Belanger","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ijid.2013.03.017_bib0045","first-page":"255","article-title":"Int\u00e9ret et limites de la s\u00e9rologie de toxoplasmose chez les sujets VIH+","volume":"39","author":"Derouin","year":"1991","journal-title":"Pathol Biol (Paris)"},{"key":"10.1016\/j.ijid.2013.03.017_bib0050","first-page":"394","article-title":"S\u00e9ropr\u00e9valence de la toxoplasmose chez 346 sujets infect\u00e9s par le VIH dans l\u2019Est de la France: suivi s\u00e9rologique des sujets non contamin\u00e9s par Toxoplasma gondii","volume":"21","author":"Candolfi","year":"1992","journal-title":"Presse Med"},{"key":"10.1016\/j.ijid.2013.03.017_bib0055","first-page":"227","article-title":"La toxoplasmose chez la femme enceinte en France en 1995. R\u00e9sultats d\u2019une enquete national p\u00e9rinatale","volume":"51","author":"Ancelle","year":"1996","journal-title":"Bulletin Epid\u00e9miologique Hebdomadaire"},{"key":"10.1016\/j.ijid.2013.03.017_bib0060","first-page":"265","article-title":"Active control of congenital toxoplasmosis in the population","volume":"6","author":"Pali\u010dka","year":"1998","journal-title":"Cent Eur J Public Health"},{"key":"10.1016\/j.ijid.2013.03.017_bib0065","series-title":"Congenital toxoplasmosis: scientific background, clinical management and control","first-page":"277","article-title":"Prevention of congenital toxoplasmosis in Austria: experience of 25 years","author":"Asp\u00f6ck","year":"2000"},{"key":"10.1016\/j.ijid.2013.03.017_bib0070","first-page":"19","article-title":"Toxoplasmose-Vorsorge bei Schwangeren und Neugeborenen in Deutschland","volume":"18","author":"Janitschke","year":"1996","journal-title":"Mitt \u00d6sterr Ges Tropenmed Parasitol"},{"key":"10.1016\/j.ijid.2013.03.017_bib0075","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1111\/j.1469-0691.2006.01513.x","article-title":"Prevalence and estimated incidence of Toxoplasma infection among pregnant women in Poland: a decreasing trend in the younger population","volume":"12","author":"Nowakowska","year":"2006","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.ijid.2013.03.017_bib0080","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1097\/00002030-200309260-00002","article-title":"Nadir CD4+ T-cell count and numbers of CD28+ CD4+ T-cells predict functional responses to immunizations in chronic HIV-1 infection","volume":"17","author":"Lange","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.03.017_bib0085","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/jac\/dkp248","article-title":"Premature immunosenescence in HIV-infected patients on highly active antiretroviral therapy with low-level CD4 T cell repopulation","volume":"64","author":"Molina-Pinelo","year":"2009","journal-title":"J Antimicrob Chemother"},{"key":"10.1016\/j.ijid.2013.03.017_bib0090","doi-asserted-by":"crossref","first-page":"6173","DOI":"10.4049\/jimmunol.1100264","article-title":"Upregulation of IL-21 receptor on B cells and IL-21 secretion distinguishes novel 2009 H1N1 vaccine responders from nonresponders among HIV-infected persons on combination antiretroviral therapy","volume":"186","author":"Pallikkuth","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2013.03.017_bib0095","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1002\/pd.1441","article-title":"Fetal serum beta2-microglobulin as a marker for fetal infectious diseases","volume":"26","author":"Dreux","year":"2006","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ijid.2013.03.017_bib0100","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000143398","article-title":"Serum beta2-microglobulin as a marker of congenital toxoplasmosis and cytomegalovirus infection in preterm neonates","volume":"94","author":"Nesovic-Ostojic","year":"2008","journal-title":"Neonatology"},{"key":"10.1016\/j.ijid.2013.03.017_bib0105","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1080\/00365540600606556","article-title":"Seroprevalence of Toxoplasma gondii in Sweden, Estonia and Iceland","volume":"38","author":"Birgisd\u00f3ttir","year":"2006","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.ijid.2013.03.017_bib0110","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1016\/S0140-6736(04)16412-X","article-title":"Toxoplasmosis","volume":"363","author":"Montoya","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.ijid.2013.03.017_bib0115","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1128\/CMR.11.4.569","article-title":"Regulation and function of T-cell-mediated immunity during Toxoplasma gondii infection","volume":"11","author":"Denkers","year":"1998","journal-title":"Clin Microbiol Rev"},{"issue":"RR-4","key":"10.1016\/j.ijid.2013.03.017_bib0120","first-page":"1","article-title":"Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America","volume":"58","author":"Kaplan","year":"2009","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ijid.2013.03.017_bib0125","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.4049\/jimmunol.143.6.2045","article-title":"Importance of endogenous IFN-gamma for prevention of toxoplasmic encephalitis in mice","volume":"143","author":"Suzuki","year":"1989","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2013.03.017_bib0130","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.4049\/jimmunol.135.6.4160","article-title":"In vivo recombinant interleukin 2 administration enhances survival against a lethal challenge with Toxoplasma gondii","volume":"135","author":"Sharma","year":"1985","journal-title":"J Immunol"},{"key":"10.1016\/j.ijid.2013.03.017_bib0135","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1126\/science.3128869","article-title":"Interferon-gamma: the major mediator of resistance against Toxoplasma gondii","volume":"240","author":"Suzuki","year":"1988","journal-title":"Science"},{"key":"10.1016\/j.ijid.2013.03.017_bib0140","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1097\/QAD.0b013e3283136d68","article-title":"Restoration of Toxoplasma gondii-specific immune responses in patients with AIDS starting HAART","volume":"22","author":"Furco","year":"2008","journal-title":"AIDS"},{"key":"10.1016\/j.ijid.2013.03.017_bib0145","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1086\/344462","article-title":"Prevalence and predictors of Toxoplasma seropositivity in women with and at risk for human immunodeficiency virus infection","volume":"35","author":"Falusi","year":"2002","journal-title":"Clin Infect Dis"}],"container-title":["International Journal of Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121300146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S120197121300146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T17:25:01Z","timestamp":1688232301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S120197121300146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S120197121300146X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijid.2013.03.017","relation":{},"ISSN":["1201-9712"],"issn-type":[{"value":"1201-9712","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Incidence and clinical and immunological characteristics of primary Toxoplasma gondii infection in HIV-infected patients","name":"articletitle","label":"Article Title"},{"value":"International Journal of Infectious Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijid.2013.03.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 International Society for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}